Back to Search
Start Over
Severe pembrolizumab-associated neutropenia after CD34 + selected allogeneic hematopoietic-cell transplantation for multiple myeloma.
- Source :
-
Bone marrow transplantation [Bone Marrow Transplant] 2018 Aug; Vol. 53 (8), pp. 1065-1068. Date of Electronic Publication: 2018 Mar 07. - Publication Year :
- 2018
- Subjects :
- Antibodies, Monoclonal, Humanized pharmacology
Antineoplastic Agents, Immunological pharmacology
Female
Hematopoietic Stem Cell Transplantation methods
Humans
Middle Aged
Multiple Myeloma pathology
Neutropenia pathology
Transplantation, Autologous methods
Transplantation, Homologous methods
Antibodies, Monoclonal, Humanized therapeutic use
Antigens, CD34 metabolism
Antineoplastic Agents, Immunological therapeutic use
Hematopoietic Stem Cell Transplantation adverse effects
Multiple Myeloma complications
Neutropenia etiology
Transplantation, Autologous adverse effects
Transplantation, Homologous adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5365
- Volume :
- 53
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- Bone marrow transplantation
- Publication Type :
- Report
- Accession number :
- 29515248
- Full Text :
- https://doi.org/10.1038/s41409-018-0142-4